NASDAQ:CBMG
Delisted
Cellular Biomedicine Group Stock News
$19.75
+0 (+0%)
At Close: May 27, 2022
Cellular Biomedicine Group, Inc. Announces Completion of Merger
02:55pm, Friday, 19'th Feb 2021
ROCKVILLE, Md. and SHANGHAI, Feb. 19, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company") today announced the completion of the merger (the "Merger") of the
Cellular Biomedicine Group, Inc. Stockholders Approve Merger
04:19pm, Monday, 08'th Feb 2021
ROCKVILLE, Md. and SHANGHAI, Feb. 8, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company") announced that, at the Company's special meeting of stockholders hel
Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger
04:30pm, Thursday, 28'th Jan 2021
ROCKVILLE, Md. and SHANGHAI, Jan. 28, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ("Company," "CBMG," "we" or "our"), a biopharmaceutical firm engaged in the drug development
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CIT, HMSY, INFO, PS, SPWH, UROV, and WDR
11:10am, Sunday, 24'th Jan 2021
NEW YORK, Jan. 24, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the
Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, CLCT, EIGI, FBM, HDS, IPHI and PNM
11:22pm, Thursday, 17'th Dec 2020
NEW YORK, Dec. 17, 2020 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the
Cellular Biomedicine Group Announces Data to be Presented at 2020 ASH Annual Meeting
07:35am, Friday, 04'th Dec 2020
GAITHERSBURG, Md. and SHANGHAI, Dec. 4, 2020 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immun
Cellular Biomedicine Group Reports Q3 2020 Financial Results and Business Highlights
05:24pm, Monday, 09'th Nov 2020
GAITHERSBURG, Md. and SHANGHAI, Nov. 9, 2020 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immun
Cellular Biomedicine Group, Inc.: 10% Return In A Few Months As Merger Should Receive Approval
02:26pm, Monday, 02'nd Nov 2020
CBMG agreed to be taken private at $19.75 per share in cash. The transaction is subject to shareholder approval as well as CFIUS clearance.
Merger Arbitrage Mondays - Gilead Sciences Acquires Immunomedics At A High Premium
11:22pm, Monday, 14'th Sep 2020
Merger activity decreased last week, with two new deals announced. The acquisition of Immunomedics by Gilead Sciences.
NEW YORK, NY / ACCESSWIRE / August 19, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:Analog Devices, Inc.
MERGER ALERT - MFAC and CBMG: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies
08:30pm, Wednesday, 19'th Aug 2020
NEW YORK, NY / ACCESSWIRE / August 19, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:Levi & Korsinsky, LLP announces that investigations have commenced on behalf of sharehold
NEW YORK, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with t
NEW YORK, NY / ACCESSWIRE / August 18, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating:Pfenex Inc.
NEW YORK, NY / ACCESSWIRE / August 17, 2020 / The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of sharehol
BALA CYNWYD, PA / ACCESSWIRE / August 17, 2020 / Brodsky & Smith, LLC reminds investors of investigations it is conducting regarding the following companies for possible breaches of fiduciary duty and
